Teicoplanin-Evultis 200 mg

Teicoplanin-Evultis 200 mg is a medicine authorised by Swissmedic under authorisation number 58808. The authorisation holder is Evultis SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 April 2009 and the authorisation is valid without a time limit. ATC code J01XA02 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 58808
  • ATC J01XA02
  • Synthetic medicines
Authorisation data
Authorisation number58808
NameTeicoplanin-Evultis 200 mg
Full nameTeicoplanin-Evultis 200 mg, Polvere e solvente per soluzione iniettabile / per infusione / soluzione orale
Authorisation holderEvultis SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01XA02
First authorisation03 April 2009
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Teicoplanin-Evultis 200 mg, Polvere e solvente per soluzione iniettabile / per infusione / soluzione oraleA03 April 2009
2Teicoplanin-Evultis 400 mg, Polvere e solvente per soluzione iniettabile / per infusione / soluzione oraleA03 April 2009

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
51 + 1Durchstechflasche(n)J01XA0208.01.9.A
61 + 1Durchstechflasche(n)J01XA0208.01.9.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Teicoplanin-Evultis 200 mg authorised in Switzerland?

Yes. Teicoplanin-Evultis 200 mg is authorised by Swissmedic under authorisation number 58808, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Teicoplanin-Evultis 200 mg have?

Teicoplanin-Evultis 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Teicoplanin-Evultis 200 mg?

The authorisation holder is Evultis SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com